Evidence Details for FEZF1


Gene Symbol: | FEZF1 ( FEZ,ZNF312B ) |
---|---|
Gene Full Name: | FEZ family zinc finger 1 |
Band: | 7q31.32 |
Quick Links | Entrez ID:389549; OMIM: 613301; Uniprot ID:FEZF1_HUMAN; ENSEMBL ID: ENSG00000128610; HGNC ID: 22788 |
Relate to Another Database: | SFARIGene; denovo-db |


>FEZF1|389549|nucleotide
ATGGACAGTAGCTGCCACAACGCGACTACCAAAATGTTAGCGACTGCTCCAGCTCGGGGCAACATGATGAGCACGTCCAAACCCTTGGCTTTCTCCATTGAACGA
ATCATGGCGCGCACCCCAGAGCCCAAGGCCCTGCCAGTCCCCCACTTCCTGCAGGGAGCCTTACCCAAGGGGGAACCCAAGCACTCTCTGCATCTCAACTCGTCG
ATCCCCTGCATGATCCCCTTCGTGCCTGTGGCCTACGACACGAGCCCCAAGGCAGGAGTGACGGGCTCCGAGCCGCGGAAGGCCAGTCTGGAGGCCCCGGCGGCG
CCCGCGGCGGTGCCCTCGGCTCCCGCATTCAGCTGCAGCGACCTGCTCAACTGCGCACTGAGTCTCAAGGGCGACCTGGCCCGCGACGCGCTGCCGCTGCAGCAG
TACAAGCTGGTAAGGCCGCGTGTGGTCAACCACTCTTCATTCCACGCCATGGGCGCCTTGTGCTACCTGAACCGAGGTGACGGCCCATGCCACCCGGCAGCCGGC
GTGAACATCCACCCGGTGGCCTCCTACTTCCTCAGTTCCCCTTTGCACCCGCAGCCAAAAACGTATTTAGCCGAAAGGAATAAACTGGTGGTCCCGGCGGTGGAG
AAATACCCTTCTGGAGTAGCTTTCAAAGACCTGTCCCAGGCTCAGCTGCAGCATTACATGAAAGAAAGCGCCCAGCTTCTGTCGGAAAAAATCGCGTTCAAAACC
TCGGATTTCAGCCGAGGCTCTCCTAATGCCAAGCCCAAAGTTTTCACTTGCGAAGTGTGTGGAAAGGTCTTTAATGCGCACTATAACTTAACCCGTCACATGCCA
GTGCACACAGGAGCCAGACCCTTCGTTTGCAAAGTGTGCGGAAAAGGTTTCAGGCAAGCAAGCACCCTGTGCAGGCACAAGATCATTCACACGCAGGAAAAACCT
CACAAATGTAACCAGTGTGGCAAAGCATTTAATAGAAGTTCCACTTTAAACACTCATACCCGAATACACGCGGGCTACAAACCGTTTGTGTGTGAATTCTGTGGC
AAAGGGTTTCATCAAAAAGGGAATTACAAAAACCACAAGTTGACCCACAGCGGGGAGAAGCAGTTCAAGTGCAATATCTGCAACAAGGCTTTCCACCAGGTTTAC
Show »
ATGGACAGTAGCTGCCACAACGCGACTACCAAAATGTTAGCGACTGCTCCAGCTCGGGGCAACATGATGAGCACGTCCAAACCCTTGGCTTTCTCCATTGAACGA
ATCATGGCGCGCACCCCAGAGCCCAAGGCCCTGCCAGTCCCCCACTTCCTGCAGGGAGCCTTACCCAAGGGGGAACCCAAGCACTCTCTGCATCTCAACTCGTCG
ATCCCCTGCATGATCCCCTTCGTGCCTGTGGCCTACGACACGAGCCCCAAGGCAGGAGTGACGGGCTCCGAGCCGCGGAAGGCCAGTCTGGAGGCCCCGGCGGCG
CCCGCGGCGGTGCCCTCGGCTCCCGCATTCAGCTGCAGCGACCTGCTCAACTGCGCACTGAGTCTCAAGGGCGACCTGGCCCGCGACGCGCTGCCGCTGCAGCAG
TACAAGCTGGTAAGGCCGCGTGTGGTCAACCACTCTTCATTCCACGCCATGGGCGCCTTGTGCTACCTGAACCGAGGTGACGGCCCATGCCACCCGGCAGCCGGC
GTGAACATCCACCCGGTGGCCTCCTACTTCCTCAGTTCCCCTTTGCACCCGCAGCCAAAAACGTATTTAGCCGAAAGGAATAAACTGGTGGTCCCGGCGGTGGAG
AAATACCCTTCTGGAGTAGCTTTCAAAGACCTGTCCCAGGCTCAGCTGCAGCATTACATGAAAGAAAGCGCCCAGCTTCTGTCGGAAAAAATCGCGTTCAAAACC
TCGGATTTCAGCCGAGGCTCTCCTAATGCCAAGCCCAAAGTTTTCACTTGCGAAGTGTGTGGAAAGGTCTTTAATGCGCACTATAACTTAACCCGTCACATGCCA
GTGCACACAGGAGCCAGACCCTTCGTTTGCAAAGTGTGCGGAAAAGGTTTCAGGCAAGCAAGCACCCTGTGCAGGCACAAGATCATTCACACGCAGGAAAAACCT
CACAAATGTAACCAGTGTGGCAAAGCATTTAATAGAAGTTCCACTTTAAACACTCATACCCGAATACACGCGGGCTACAAACCGTTTGTGTGTGAATTCTGTGGC
AAAGGGTTTCATCAAAAAGGGAATTACAAAAACCACAAGTTGACCCACAGCGGGGAGAAGCAGTTCAAGTGCAATATCTGCAACAAGGCTTTCCACCAGGTTTAC
Show »
>FEZF1|389549|protein
MDSSCHNATTKMLATAPARGNMMSTSKPLAFSIERIMARTPEPKALPVPHFLQGALPKGEPKHSLHLNSSIPCMIPFVPVAYDTSPKAGVTGSEPRKASLEAPAA
PAAVPSAPAFSCSDLLNCALSLKGDLARDALPLQQYKLVRPRVVNHSSFHAMGALCYLNRGDGPCHPAAGVNIHPVASYFLSSPLHPQPKTYLAERNKLVVPAVE
KYPSGVAFKDLSQAQLQHYMKESAQLLSEKIAFKTSDFSRGSPNAKPKVFTCEVCGKVFNAHYNLTRHMPVHTGARPFVCKVCGKGFRQASTLCRHKIIHTQEKP
HKCNQCGKAFNRSSTLNTHTRIHAGYKPFVCEFCGKGFHQKGNYKNHKLTHSGEKQFKCNICNKAFHQVYNLTFHMHTHNDKKPFTCPTCGKGFCRNFDLKKHVR
KLHDSSLGLARTPAGEPGTEPPPPLPQQPPMTLPPLQPPLPTPGPLQPGLHQGHQ
Show »
MDSSCHNATTKMLATAPARGNMMSTSKPLAFSIERIMARTPEPKALPVPHFLQGALPKGEPKHSLHLNSSIPCMIPFVPVAYDTSPKAGVTGSEPRKASLEAPAA
PAAVPSAPAFSCSDLLNCALSLKGDLARDALPLQQYKLVRPRVVNHSSFHAMGALCYLNRGDGPCHPAAGVNIHPVASYFLSSPLHPQPKTYLAERNKLVVPAVE
KYPSGVAFKDLSQAQLQHYMKESAQLLSEKIAFKTSDFSRGSPNAKPKVFTCEVCGKVFNAHYNLTRHMPVHTGARPFVCKVCGKGFRQASTLCRHKIIHTQEKP
HKCNQCGKAFNRSSTLNTHTRIHAGYKPFVCEFCGKGFHQKGNYKNHKLTHSGEKQFKCNICNKAFHQVYNLTFHMHTHNDKKPFTCPTCGKGFCRNFDLKKHVR
KLHDSSLGLARTPAGEPGTEPPPPLPQQPPMTLPPLQPPLPTPGPLQPGLHQGHQ
Show »


Click the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default.
Evidences | Syndromic Gene | GWAS | CNV | Linkage | Association | Expression | NGS de novo | NGS Mosaic | NGS Other | Low-Scale Gene Studies | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Score (No. of Studies) | No | 2 (2) | 0 (5) | 1 (1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (1) | 0 (0) | 18 (9) |




Family Based Association Studies: 0
Reference | Stage | Platform | #Families | Affecteds | Result | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
#Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Age (range) |
IQ (range) |
|||||||
No Evidence. |
Case Control Based Association Studies: 2
Reference | Stage | Platform | ASD Cases | Normal Controls | Result | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
#Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Age (range) |
IQ | #Subjects (% Women) |
Age (range) |
|||||
CAUCASIAN | ||||||||||||
Maestrini, 2009_5 | Discovery | GoldenGate assay (Illumina, San Diego, CA, USA) | 127 (20.47%) | ![]() | ![]() | ASD | - - |
- | 188 (21.28%) |
- - | ||
Maestrini, 2009_6 | Replication | the Mass Extend iPLEX Gold (Sequenom, San Diego, CA, USA) and TaqMan platforms | 294 (19.73%) | ![]() | ![]() | ASD | - - |
- | 180 (20.00%) |
- - |


Reference | Source | Method | ADI-R | ADOS | Diagnosis | Family | Individual | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Simplex | Multiplex | Control | Affected | Control | Total | ||||||
Marshall, 2008 | - | SNP microarray | ![]() | ![]() | ASD | 427 | 238 | 189 | - | 427 | 500 | 927 |
Christian, 2008 | USA | aCGH | ![]() | ![]() | ASD | 397 | 35 | 362 | - | 397 | 372 | 769 |
Gai, 2011 | AGRE | SNP microarray | - | - | autism | - | - | - | - | 1224 | 3801 | 5025 |
Okamoto, 2011 | Japan | - | ![]() | ![]() | ASD | - | - | - | - | 1 | - | 1 |
Sanders, 2011 | Simons Simplex Collection | SNP microarray | - | - | ASD | 1127 | 1127 | - | - | - | - | - |


Reference | Source | Method | ADI-R | ADOS | Diagnosis | Family | Individual | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Simplex | Multiplex | Control | Affected | Control | Total | ||||||
Allen-Brady, 2010 | USA | SNP-based genomic screen | ![]() | ![]() | ASD | 40 | - | 40 | - | 192 | 461 | 653 |










Reference | Source | Platform | ADI-R | ADOS | Diagnosis | Family | Affected | Validation Method | ||
---|---|---|---|---|---|---|---|---|---|---|
Total | Simplex | Multiplex | ||||||||
Chapman NH, 2015 | - | Illumina HIseq2000 | ![]() | ![]() | ASD | 7 | - | - | - | Sanger sequencing |


Contact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.